WallStreetZenWallStreetZen

NYSE: CDRE
Cadre Holdings Inc Stock

Overview
ForecastEarningsRevenueDividendOwnership
$30.45+0.37 (+1.23%)
Updated Apr 25, 2025
CDRE Price
$30.45
Fair Value Price
N/A
Market Cap
$1.24B
52 Week Low
$27.07
52 Week High
$40.28
P/E
33.83x
P/B
3.97x
P/S
2.27x
PEG
1.46x
Dividend Yield
0.62%
Revenue
$567.56M
Earnings
$36.13M
Gross Margin
41.1%
Operating Margin
10.93%
Profit Margin
6.4%
Debt to Equity
1.1
Operating Cash Flow
$32M
Beta
0.81
Next Earnings
May 30, 2025
Ex-Dividend
N/A
Next Dividend
N/A

CDRE Overview

Cadre Holdings, Inc. provides safety and survivability equipment to users (including first responders) in potentially hazardous or life-threatening situations in the U.S. and internationally. Offerings include body armor, explosive ordnance disposal equipment, duty gear, light sticks, chemiluminescent ammunition, and infra-red devices. It also sell third-party uniforms, boots, firearms, and ammunition. The company was founded in 1964 and is headquartered in Jacksonville, FL.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine CDRE's potential to beat the market

BBuy
  • Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More
View All “A” Zen Rated Stocks
→

Zen Rating Component Grades

C
Value
B
Growth
C
Momentum
C
Sentiment
C
Safety
B
Financials
B
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Defense

Industry Rating
C
CDRE
Ranked#11 of 64

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
Sturm Ruger & Co (RGR)
$40.33A
Tat Technologies (TATT)
$25.40A
Elbit Systems (ESLT)
$379.54A
View Top Defense Stocks

Be the first to know about important CDRE news, forecast changes, insider trades & much more!

CDRE News

Overview

Due Diligence Score

–
Industry Average (31)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CDRE scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CDRE ($30.45) is trading above its intrinsic value of $12.19, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CDRE is poor value based on its earnings relative to its share price (33.83x), compared to the US market average (29.65x)
P/E vs Market Valuation
CDRE is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CDRE due diligence checks available for Premium users.

Valuation

CDRE price to earnings (PE)

For valuing profitable companies with steady earnings

Company
33.83x
Industry
40.86x
Market
29.65x
CDRE is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CDRE is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

CDRE price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
3.97x
Industry
5.81x
CDRE is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CDRE price to earnings growth (PEG)

For valuing profitable companies with growth potential

CDRE is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

CDRE's financial health

Profit margin

Revenue
$176.0M
Net Income
$13.0M
Profit Margin
7.4%
CDRE's Earnings (EBIT) of $62.04M... subscribe to Premium to read more.
Interest Coverage Financials
CDRE's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$652.7M
Liabilities
$341.2M
Debt to equity
1.1
CDRE's short-term assets ($327.57M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CDRE's short-term assets ($327.57M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CDRE's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CDRE's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$23.7M
Investing
-$1.3M
Financing
$9.8M
CDRE's operating cash flow ($31.78M)... subscribe to Premium to read more.
Debt Coverage Financials

CDRE vs Defense Stocks

TickerZen RatingMarket Cap1d %P/EP/B
CDREB$1.24B+1.23%33.83x3.97x
EHC$1.22B+1.19%-36.20x9.31x
EVEXD$1.09B-4.95%-7.60x8.77x
PLD$1.02B+1.19%-8.07x2.32x
LUNRD$1.53B+2.39%-1.85x-1.52x
View Top Defense Stocks

Cadre Holdings Stock FAQ

What is Cadre Holdings's quote symbol?

(NYSE: CDRE) Cadre Holdings trades on the NYSE under the ticker symbol CDRE. Cadre Holdings stock quotes can also be displayed as NYSE: CDRE.

If you're new to stock investing, here's how to buy Cadre Holdings stock.

What is the 52 week high and low for Cadre Holdings (NYSE: CDRE)?

(NYSE: CDRE) Cadre Holdings's 52-week high was $40.28, and its 52-week low was $27.07. It is currently -24.4% from its 52-week high and 12.47% from its 52-week low.

How much is Cadre Holdings stock worth today?

(NYSE: CDRE) Cadre Holdings currently has 40,607,988 outstanding shares. With Cadre Holdings stock trading at $30.45 per share, the total value of Cadre Holdings stock (market capitalization) is $1.24B.

Cadre Holdings stock was originally listed at a price of $15.29 in Nov 4, 2021. If you had invested in Cadre Holdings stock at $15.29, your return over the last 3 years would have been 99.15%, for an annualized return of 25.81% (not including any dividends or dividend reinvestments).

How much is Cadre Holdings's stock price per share?

(NYSE: CDRE) Cadre Holdings stock price per share is $30.45 today (as of Apr 25, 2025).

What is Cadre Holdings's Market Cap?

(NYSE: CDRE) Cadre Holdings's market cap is $1.24B, as of Apr 26, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Cadre Holdings's market cap is calculated by multiplying CDRE's current stock price of $30.45 by CDRE's total outstanding shares of 40,607,988.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.